A randomized, phase 2 study of ASP0113, a DNA ‐based vaccine, for the prevention of CMV in CMV‐seronegative kidney transplant recipients receiving a kidney from a CMV‐seropositive donor

American Journal of Transplantation, EarlyView.

Source: American Journal of Transplantation - June 20, 2018 Category: Transplant Surgery Authors: Flavio Vincenti , Klemens Budde , Pierre Merville , Fuad Shihab , V. Ram Peddi , Malay Shah , Kate Wyburn , Elisabeth Cassuto ‐Viguier , Alexander Weidemann , Misun Lee , Teresa Flegel , Jay Erdman , Xue Source Type: research